Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
EHE treatment is highly individualized, involving surgery, ablation, chemotherapy, and mTOR inhibitors, depending on patient-specific factors. Next-generation sequencing helps identify genetic ...
The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback